NutraMax Cough/Cold Sales Increase 12% In First Quarter
This article was originally published in The Tan Sheet
Executive Summary
NutraMax sales for its cough/cold division increased 12% for the first quarter ended Jan. 2, despite last year's quarter finishing with one additional week. Comparing equivalent 13-week periods, sales in the cough/cold division increased 20%, the company said in a teleconference with securities analysts Jan. 26.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning